Skip to main
ONPH

Oncology Pharma Inc. (ONPH)


$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy ONPH Stock

About Oncology Pharma Inc. (ONPH)

Oncology Pharma, Inc. engages in the development, manufacture and commercialization of therapeutics. The company was founded by Marcel van Heesewijk on March 26, 1993 and is headquartered in San Francisco, CA.
Market cap$150.6K
Yesterday's volume61
Revenue (TTM)
Avg. daily volume8.27K
EBITDA (TTM)
Open$0.01
Price / earnings ratio
Yesterday's range$0.01 - $0.01
Debt / equity
52 week range
5 year debt / equity
Beta (LTM)-81.98x
Interest coverage
Dividend & yield$0.00 (0.00%)
Current ratio
Ex-dividend date
Next earnings
Dividend payable date

Frequently Asked Questions (FAQ)

As of Jan 27, 2026, the market cap for ONPH stock is $150.6K

The 52-week high for ONPH stock is $0.01. The current ONPH stock price $undefined is 100.00% below its 52-week high

No, the ONPH stock does not pay dividends to its shareholders

How to buy ONPH stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in ONPH stock

    Navigate to the Explore page. Then, type ONPH into the search bar. When you see ONPH stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased ONPH stock in your portfolio alongside the rest of your stocks, ETFs, crypto, bonds, options, and your high-yield cash account––all in one place on Public.

Buy ONPH Stock

Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.